Vanessa Vankerckhoven
Antwerp, Belgium
CEO and Co-Founder of Novosanis, a University of Antwerp spin-off company working on the design, manufacturing and production of medical devices ranging from injection devices to in vitro diagnostics.
Previously employed as Research & Innovation Manager of the Vaccine and Infectious Disease Institute at the University of Antwerp, responsible for assessing technology transfer opportunities within the Institute and facilitating collaborations with research and industrial partners.
PhD in Medical Sciences at the University of Antwerp, Belgium. PhD on Biosafety of probiotics for human use.